CN109276537A - A kind of composite hydrogel and its preparation and application of load vascular disrupting agents and near infrared light thermal response nanoparticle altogether - Google Patents

A kind of composite hydrogel and its preparation and application of load vascular disrupting agents and near infrared light thermal response nanoparticle altogether Download PDF

Info

Publication number
CN109276537A
CN109276537A CN201811064878.6A CN201811064878A CN109276537A CN 109276537 A CN109276537 A CN 109276537A CN 201811064878 A CN201811064878 A CN 201811064878A CN 109276537 A CN109276537 A CN 109276537A
Authority
CN
China
Prior art keywords
hydrogel
composite hydrogel
infrared light
near infrared
disrupting agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201811064878.6A
Other languages
Chinese (zh)
Other versions
CN109276537B (en
Inventor
李娟�
梁育晴
郝义俊
孙晓毅
刘又年
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Central South University
Original Assignee
Central South University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Central South University filed Critical Central South University
Priority to CN201811064878.6A priority Critical patent/CN109276537B/en
Publication of CN109276537A publication Critical patent/CN109276537A/en
Application granted granted Critical
Publication of CN109276537B publication Critical patent/CN109276537B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/075Ethers or acetals
    • A61K31/085Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0052Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a kind of injectable composite hydrogels and antitumor application thereof for loading vascular disrupting agents and near infrared light thermal response nanoparticle altogether.Composite hydrogel includes hydrogel substrate material, and the vascular disrupting agents and near infrared light thermal response nanoparticle that are supported in hydrogel substrate material.Nanometer composite hydrogel produced by the present invention has the sol-gel transition behavior of syringeability and heat stagnation.Under the irradiation of near infrared light, hybridized hydrogel of the invention has very excellent photo-thermal property, and the curative effect of vascular disrupting agents is improved by enhancing tumor vessel permeability.Good safety and curative effect are showed in anti-tumor aspect using vascular disrupting agents and the hybridized hydrogel of photo-thermal combination therapy.

Description

A kind of Compound Water loading vascular disrupting agents and near infrared light thermal response nanoparticle altogether Gel and its preparation and application
Technical field
The present invention relates to a kind of injection aquagels for loading vascular disrupting agents and near infrared light thermal response nanoparticle altogether And antitumor application thereof, belong to pharmacy, oncology.
Background technique
Tumor tissues are made of essence and interstitial two parts, and tumor epithelial cell is tumour cell, are the main components of tumour, tool Organized source specificity.The interstitial of tumour plays support and nutrition tumor epithelial cell, does not have specificity, including connective group It knits, blood vessel, lymphatic vessel etc..
Vascular disrupting agents (vascular disrupting agents, abbreviation VDAs) are a kind of swollen with selective injury The anti-tumor drug of tumor relevant blood vessel.This kind of drug blocks the battalion of tumor tissues by selectively destroying tumor-associated vessels Substance and oxygen supply are supported, secondary tumors cell death is caused, to achieve the purpose that targeting therapy on tumor.However, due to The poorly water-soluble of vasoinhibitor (such as health cloth sting A4 etc.), the originals such as half-life short, bioavilability is very low, permeability is insufficient Cause, single vascular disrupting agents treatment frequently result in failure and the tumor recurrence of oncotherapy.
Near infrared light heat cure is the antitumor physical method of one kind of latest developments, is had using near infrared light (NIR) The advantages that wavelength is longer, penetrability is strong, not only can be with right place rapidly local ablation tumor tissues, can also be according to infrared The intensity of line transmitting and the related progress infrared thermal imaging of the temperature of object, photoacoustic imaging etc..Commonly optical-thermal conversion material includes C-based nanomaterial (such as graphene etc.), nano semiconductor material (such as copper sulfide, bismuth selenide etc.), noble metal nano particles (such as gold, platinum etc.).Prussian blue is Fe2+And Fe3+Six ferricyanides of mixed valence, preparation method is simple, mild condition, It clinically can be used for treating thallium radiation poisoning, there is good biological safety and metabolic pathway in human body.Research hair Existing prussian blue nano particle has the function of near infrared light fuel factor and magnetic resonance imaging enhancing.Single photo-thermal therapy is anti-swollen It is general only to small size tumour (< 100mm when tumor3) effectively, and it is bad to be easy to cause thermal burn, pain over the course for the treatment of etc. Phenomenon.
Currently, the hydrogel near infrared light response of research report is mainly your gold that one kind includes photo-thermal property Hydrogel { the Biomaterials 2016,104,129-137 of metal nano-particle (such as nano platinum particle, gold nanoparticle); Adv.Funct.Mater.2018,28 (21), 1801000 }, and concentrate on the combination therapy of both photo-thermal and chemotherapy.Many institute's weeks Know, side effects of chemotherapy is big, is easy to produce drug resistance.There is not yet hydrogel carrier is total to load vascular disrupting agents and near-infrared photo-thermal Response nano particle is to realize the document report of photo-thermal and vascular disrupting agents combination therapy.
Summary of the invention
An object of the present invention is to provide a kind of load vascular disrupting agents and near infrared light thermal response nanoparticle altogether Composite hydrogel.
Second purpose of the invention is, provides the preparation method of composite hydrogel described in one kind.
Third purpose of the present invention is, provides composite hydrogel application in preparation of anti-tumor drugs described in one kind.
A kind of composite hydrogel loading vascular disrupting agents and near infrared light thermal response nanoparticle altogether, including water-setting matrix Bottom material, the vascular disrupting agents being supported in hydrogel substrate material and near infrared light thermal response nanoparticle.
Composite hydrogel of the invention be based on hydrogel substrate material comprising near infrared light thermal response nanoparticle and The Nanometer composite hydrogel of vascular disrupting agents.The present invention innovatively has found, by vascular disrupting agents and near infrared light thermal response nanometer Particle loads on the hydrogel, has obvious synergistic purpose, can promote mutual anti-tumor activity, hence it is evident that improves anti-swollen Tumor effect, moreover, the present inventors have additionally discovered that, vascular disrupting agents and near infrared light thermal response nanoparticle are supported on together On hydrogel, the purpose of long-acting can be realized by sustained release to avoid the burst release of vascular disrupting agents.Antitumor reality in Mice Body Test the result shows that, compared to VDAs/ hydrogel and PB/ hydrogel is used alone, the experimental group tool that uses composite hydrogel to handle There is better antitumous effect, it almost can complete tumor resection.
Near infrared light thermal response nanoparticle of the present invention needs to turn with good biocompatibility, higher photo-thermal Change the material of efficiency and preferable photo and thermal stability.
Preferably, the near infrared light thermal response nanoparticle is mesoporous prussian blue nano particle ((Prussian Blue, abbreviation PB), at least one of platinum and metal chalcogenide compound.
Further preferably, the near infrared light thermal response nanoparticle is mesoporous prussian blue nano particle. The study found that the synergy of preferred PB and vascular disrupting agents and hydrogel substrate material is more excellent, association can be further promoted Same effect.
Further preferably, the partial size of the near infrared light thermal response nanoparticle is 20~200nm.
Still more preferably, the near infrared light thermal response nanoparticle is particle diameter distribution in 20~200nm range, most Mesoporous prussian blue nano particle of the big absorbing wavelength in 720nm or so.
Prussian blue nano particle described in hydrogel of the invention by polyvinylpyrrolidone (PVP) restore dispersion method, Sodium citrate modifies the preparation of the methods of the precipitation method, hydro-thermal etching method.
Preferably, the vascular disrupting agents are health cloth sting A4 (CA4), health cloth sting A4 water-soluble phosphate precursor medicine At least one of object CA4P, DMXAA and TZT-1027;Preferably CA4.The present inventor is the study found that preferred CA4 and described The composite hydrogel of near infrared light thermal response nanoparticle there is more preferably synergy, can further be promoted it is antitumor and Slow release effect.
Hydrogel matrix material of the present invention is a kind of natural polysaccharide with highest critical solution temperature (UCST), and Sol-gel transition behavior with heat stagnation can cooperate with the other compositions in composite hydrogel, make in composite hydrogel The fuel factor generated under nanoparticle illumination, prevents the burst release of vascular disrupting agents, and keeps vascular disrupting agents in tumor locus Relatively high local concentration and therapeutic effect.
Preferably, hydrogel substrate material is temperature-sensitive hydrogel;Preferably, the hydrogel substrate material has Syringeability.
Hydrogel substrate material is more preferably at least one of gellan gum, agar.Preferred base material, it is more sharp In the performance for promoting composite hydrogel, the situ treatment ability and biocompatibility of material are further promoted.
Still more preferably, hydrogel substrate material is gellan gum;Most preferably low-acyl gellan gum.
The research of the invention finds that it is good that the composite hydrogel can be assigned under the component collaboration of the innovation Antitumous effect, research it has furthermore been found that control component between proportionate relationship, can further promote the synergisticing performance.
Preferably, hydrogel substrate material mass percent concentration is 0.5%~5%, closely in the composite hydrogel The mass concentration of infrared photothermal response nanoparticle is 0.01~1.0mg/mL, and vascular disrupting agents concentration is in 1.0~10.0mg/ mL。
Further preferably, in the composite hydrogel, hydrogel substrate material is gellan gum, near infrared light thermal response nanometer Particle is the PB, vascular disrupting agents CA4 of 20~200nm;Wherein, gellan gum mass percent concentration is 0.5%~5%, PB Mass concentration is 0.05~1mg/mL, and vascular disrupting agents concentration is in 1~10mg/mL.
The invention discloses a kind of preparation methods of composite hydrogel, by vascular disrupting agents, near infrared light thermal response Nanoparticle and the mixing of hydrogel matrix material and water, are made the composite hydrogel.
Preparation method of the present invention exists vascular disrupting agents, near infrared light thermal response nanoparticle and host material The composite hydrogel is made in gelation in water.
Preferably, hydrogel matrix material is added in the dispersion liquid for being dispersed near infrared light thermal response nanoparticle and adds After heat of solution, it is cooled to the temperature range addition vascular disrupting agents drug that not will lead to drug inactivation, is cooled to room temperature, i.e., ?.
Still more preferably, it the preparation method: after gellan gum is dissolved by heating with water, is cooled to and not will lead to drug PB, vascular disrupting agents drug is added in the temperature range of inactivation, then cooling mixed aqueous solution can be obtained to room temperature comprising PB nanometers The gellan gum Nanometer composite hydrogel system of particle and vascular disrupting agents.
Composite hydrogel of the present invention has the characteristics that preparation method is simple, treatment is easy to operate.Selected three Kind material mixing can be obtained by Nanometer composite hydrogel.When treatment, it is only necessary to intratumor injection and primary or close for several times Infrared light shines can cure tumour completely.
The present invention also provides the applications of the composite hydrogel, are used to prepare anti-tumor drug;
Preferably, it is used to prepare the drug of neoplasm in situ treatment;
Further preferably, it is used to prepare the drug of anti-malignant sarcomas.
Most preferably, the application, which is characterized in that be used to prepare antitumor ejection preparation.
The present invention also provides a kind of antitumor ejection preparations, and it includes the composite hydrogels.
Beneficial effect
Composite hydrogel of the present invention has efficient antitumor action by the collaboration of component.Work as near infrared light When irradiation, Nanometer composite hydrogel generates fuel factor, can not only enhance tumor infiltrating, can also weaken hydrogel substrate material Interaction between (such as gellan gum) molecule, to enhance gel network mobility, vascular disrupting agents are gradually spread therewith To the neighboring area of injection site, tumor vascular comprehensive collapsing and tumor cell necrosis can be caused.Due to gellan gum water-setting The heating stagnation curve of glue, gel will not be destroyed all in temperature-rise period, and the substance coated can be retained in tumor tissues Near, preferably extend drug treating time, achievees the purpose that administration in situ, long-acting.
In addition, the present invention can solve vascular disrupting agents poorly water-soluble, half-life period by the collaboration between component well The short, technical problems such as bioavilability is very low, permeability is insufficient;Moreover, moreover it is possible to pass through the near infrared light thermal response Nanoparticle cooperates the hydrogel substrate material, regulates and controls the release and tissue permeability of effective component, reaches and significantly mention Rise the purpose of antitumous effect.
Nanometer composite hydrogel of the invention simple combination absolutely not, by the collaboration of each component, described is compound There is hydrogel the sol-gel transition behavior of heat stagnation, the fuel factor generated under light illumination not will cause vascular disrupting agents Burst release can make vascular disrupting agents keep relatively high local concentration and therapeutic effect in tumor locus;Moreover, institute of the present invention The composite hydrogel stated has syringeability and improves tumor vessel permeability, it can be achieved that efficient therapeutic purposes in situ, effectively It ensure that the composite hydrogel in the good safety of anti-tumor aspect and curative effect.
Detailed description of the invention
The rheological equationm of state of 4 Nanometer composite hydrogel of Fig. 1 embodiment in heating and temperature-fall period
The shear shinning property of 4 Nanometer composite hydrogel of Fig. 2 embodiment
The strain sweep curve of 4 Nanometer composite hydrogel of Fig. 3 embodiment
The Cyclic Strain scanning curve of 3 Nanometer composite hydrogels of Fig. 4 embodiment 4
The absorption spectrum of 4 Nanometer composite hydrogel of Fig. 5 embodiment
The photo-thermal property figure of 4 Nanometer composite hydrogel of Fig. 6 embodiment
The light-operated release profiles of 6 Nanometer composite hydrogel of Fig. 7 embodiment
The antitumous effect figure of 7 Nanometer composite hydrogel of Fig. 8 embodiment
The antitumor quantization figure of 7 Nanometer composite hydrogel of Fig. 9 embodiment
Specific embodiment
Following embodiment is intended to illustrate invention rather than limitation of the invention further.
Embodiment 1.
Polyvinylpyrrolidone (PVP) restores dispersion method and prepares prussian blue nano particle
Weigh 15g polyvinylpyrrolidone (PVP) and 664mg potassium ferricyanide (K3[Fe(CN)6]), 200mL 0.01M is added 30min is stirred at room temperature in HCl, is transferred in 80 DEG C of thermostatical oil baths and reacts 20h, is cooled to room temperature after reaction, high speed centrifugation 20min removes supernatant, with secondary water washing to neutrality, is lyophilized spare.
2. sodium citrate of embodiment modifies the precipitation method and prepares prussian blue nano particle
It weighs 0.10g sodium citrate and 20mL FeCl is added3In (1mM) solution, weighs 0.10g sodium citrate and 20mL is added K4[Fe(CN)6] in (1mM) aqueous solution, under 60 DEG C of constant temperature stirrings, by sodium citrate/K4[Fe(CN)6] mixed solution is added dropwise In sodium citrate/FeCl3 mixed solution, after it is cooled to room temperature, continuing stirring 30min can be obtained prussian blue nano grain Son.
The preparation of the mesoporous prussian blue nano particle of embodiment 3.
Prussian blue (Prussian blue, the PB) nanoparticle of 0.08g and 125mg PVP are weighed, 80mL is added to In 1.0M HCl, 30min is stirred, is transferred in 100mL reaction kettle, is placed in 140 DEG C of baking ovens and reacts 4h, high speed centrifugation 20min is received Collection precipitating is lyophilized spare with secondary water washing to neutrality.
Embodiment 4. loads the Nanometer composite hydrogel of prussian blue nano particle and CA4 altogether
It weighs 0.2g gellan gum (acyl group low with Guang Chun industry Industrial Co., Ltd) and 10mL 0.1mg/mL PB (example 3) is added In ultrasonic disperse liquid, after mixing, it is placed in 85 DEG C of thermostat water baths, after completely dissolution to gellan gum, mixed solution is placed in 50 Place 1h in DEG C thermostat water bath, add 60mg CA4, after being sufficiently mixed uniformly, be cooled to room temperature can be obtained cladding PB with The Nanometer composite hydrogel of CA4, sample are placed in 4 DEG C of refrigerators and are kept in dark place that (Product Labeling is CA4+PB@gellan hydrogel)。
Embodiment 5. loads the Nanometer composite hydrogel of prussian blue nano particle and CA4P altogether
It weighs 0.2g gellan gum to be added in 10mL 0.1mg/mL PB ultrasonic disperse liquid (example 3), after mixing, is placed in 85 DEG C In thermostat water bath, after completely dissolution to gellan gum, mixed solution is placed in 50 DEG C of thermostat water baths and places 1h, is added 30mg CA4P after being sufficiently mixed uniformly, is cooled to the Nanometer composite hydrogel that cladding PB and CA4P can be obtained in room temperature, and sample is set (Product Labeling is CA4P+PB@gellan hydrogel) is kept in dark place in 4 DEG C of refrigerators.
The release experiment of 6. Nanometer composite hydrogel of embodiment
Two parts of 1.0g of Nanometer composite hydrogel prepared by embodiment 5 are weighed, it is slow to be separately added into 7.4 PBS of 2.0mL pH Fliud flushing is placed in 37 DEG C of water bath with thermostatic control shaking tables as dissolution medium and simulates release.A copy of it sample applies 1.0W/cm2's (temperature is increased to 54 DEG C) closes laser after 808nm laser irradiation 5min, so repeats four light cycles.Another is Control group without laser irradiation.It is quantitative to the drug concentration in dissolution medium at specific time point, and draw accumulation drug and release Put kinetic curve.
The anti-tumor experiment of 7. Nanometer composite hydrogel of embodiment
After mouse shaving, the physiological saline of 100 μ L cells containing 4T1 is subcutaneously injected, about back of mice is grown after a week for raising About 150mm3The tumour of size.Mouse is randomly divided into 6 groups (every group 5): (1) blank control group is physiological saline PBS;(2) PB (example 3)+NIR, 0.1mg/mLPB;(3)PB@gellan hydrogel+NIR;(4) CA4,6mg/mL;(5)CA4@ gellan hydrogel;(6) CA4+PB@gellan hydrogel (example 3)+NIR.Respectively by the sample of different experiments group into Row mouse intratumor injection, the intratumor injection sample volume of every mouse are 200uL.Inject about 2h after, respectively to group (2), (3) and (6) every mouse tumor position applies 808nm laser irradiation 3min, optical power density 1W/cm2.Every other day record is swollen Knurl product and mouse weight, after treatment 22 days, after mouse is put to death in etherization, tumor tissues are collected in dissection.
Nanometer composite hydrogel (CA4+PB@gellan hydrogel) is made in heating and temperature-fall period performance in the present invention The different rheological equationms of state, temperature lowering curve show that the sol-gel transition temperature of Nanometer composite hydrogel is about 52 DEG C, and it is bent to heat up There is not Gel-sol transition temperature in line Nanometer composite hydrogel, illustrates the heat stagnation (Fig. 1) of Nanometer composite hydrogel.
Nanometer composite hydrogel, which is made, in the present invention has good syringeability and self- recoverage property.Rheometer characterizes miscellaneous Change the shear shinning property of gel, with the raising of shear rate, viscosity is gradually reduced, and has invertibity (Fig. 2).Hydridization The storage modulus of gel can be gradually reduced with the increase of strain, and when strain is approximately more than 6%, G ' < G " shows as fluidity Matter (Fig. 3).Nanometer composite hydrogel is under 300% effects of strain, storage modulu G ' sharp fall (G ' < G "), illustrates solidifying Glue is destroyed, and when strain is 1%, gelation immediately occurs again in 10s for system, and modulus is restored close to initial level, and This process can be recycled repeatedly, illustrate that hybrid gel has extraordinary self-healing property (Fig. 4).
The maximum absorbing wavelength of Nanometer composite hydrogel is made near 720nm (Fig. 5) in the present invention.It is closely red in 808nm Under the stimulation of outer light, Nanometer composite hydrogel of the invention has very excellent photo-thermal property.The variation of temperature and near-infrared The irradiation time of light is directly proportional to power (Fig. 6).In 1.0W/cm2Power illumination 5min, PB mass concentration in 0.1mg/mL, Temperature can rise 50 DEG C.Although Nanometer composite hydrogel of the invention can generate thermal effect under the irradiation of 808nm near infrared light It answers, but illumination influences less the rate of release of vascular disrupting agents, hydrogel does not show burst release after near infrared light photograph, still Have the characteristics that slow release drug (Fig. 7).
By establishing mouse subcutaneous tumor, gross tumor volume is more than 150mm3When, after 200 μ L hydrogels are subcutaneously injected, and give Give near infrared light (808nm, a 1.0W/cm2, 3min).Research is found and single photo-thermal therapy or vascular disrupting agents Treatment control group compares, and experimental group (CA4+PB@gellan hydrogel) has optimal antitumor synergy.Treatment 22 Discovery is dissected after it, 5 mouse gross tumor volume after treating all contracts significantly in experimental group (CA4+PB@gellan hydrogel) It is small, wherein 2 mouse tumor tissues completely disappear, show that photo-thermal therapy can press down completely with vascular disrupting agents combination therapy means System even melts the tumour (Fig. 8) of mouse.
Treat the volume change of tumour in latter 22 days as shown in figure 9, tumour is substantially completely cut off.Compared to control group Speech, PB+gellan have preferable oncotherapy effect compared to individual PB, and similarly, CA4+gellan is compared to individual CA4 has better treatment of cancer effect, but the phase all shows apparent growth trend to the tumour of four groups of mouse after the treatment, makes There is better antitumous effect with the experimental group that composite hydrogel is handled.

Claims (10)

1. a kind of composite hydrogel for loading vascular disrupting agents and near infrared light thermal response nanoparticle altogether, which is characterized in that packet Hydrogel substrate material is included, and the vascular disrupting agents and near infrared light thermal response nanoparticle that are supported in hydrogel substrate material Son.
2. composite hydrogel according to claim 1, which is characterized in that the near infrared light thermal response nanoparticle is to be situated between At least one of hole prussian blue nano particle, platinum and metal chalcogenide compound;It is further preferably mesoporous Prussian blue to receive Rice corpuscles.
3. composite hydrogel according to claim 2, which is characterized in that the grain of the near infrared light thermal response nanoparticle Diameter is 20~200nm.
4. composite hydrogel according to claim 1, which is characterized in that the vascular disrupting agents are health cloth sting A4, Kang Bu At least one of sting A4 water-soluble phosphate pro-drug CA4P, DMXAA and TZT-1027;Preferably health cloth sting A4.
5. composite hydrogel according to claim 1, which is characterized in that hydrogel substrate material is in gellan gum or agar At least one.
6. composite hydrogel according to claim 5, which is characterized in that the gellan gum is low-acyl gellan gum.
7. any one composite hydrogel according to claim 1~6, which is characterized in that in the Nanometer composite hydrogel, Hydrogel substrate material mass percent concentration is 0.5%~5%, and the mass concentration of near infrared light thermal response nanoparticle is 0.01~1.0mg/mL, vascular disrupting agents concentration is in 1.0~10.0mg/mL.
8. a kind of preparation method of any one of claim 1~7 composite hydrogel, which is characterized in that by vascular disrupting agents, Near infrared light thermal response nanoparticle and the dissolution of hydrogel matrix material and water mixing, are made the composite hydrogel;
Preferably, hydrogel matrix material is added in the dispersion liquid for being dispersed near infrared light thermal response nanoparticle and heats molten Xie Hou, be cooled to not will lead to drug inactivation temperature range be added vascular disrupting agents drug, be cooled to room temperature to get.
9. compound water congealing made from preparation method described in composite hydrogel described in a kind of claim 1~7 or claim 8 The application of glue, which is characterized in that be used to prepare anti-tumor drug;
Preferably, it is used to prepare the drug of neoplasm in situ treatment;
Further preferably, it is used to prepare the drug of anti-malignant sarcomas.
10. a kind of antitumor ejection preparation, which is characterized in that include any one of claim 1~7 composite hydrogel.
CN201811064878.6A 2018-09-12 2018-09-12 Composite hydrogel co-loaded with vascular disrupting agent and near-infrared photothermal response nanoparticles, and preparation and application thereof Expired - Fee Related CN109276537B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811064878.6A CN109276537B (en) 2018-09-12 2018-09-12 Composite hydrogel co-loaded with vascular disrupting agent and near-infrared photothermal response nanoparticles, and preparation and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811064878.6A CN109276537B (en) 2018-09-12 2018-09-12 Composite hydrogel co-loaded with vascular disrupting agent and near-infrared photothermal response nanoparticles, and preparation and application thereof

Publications (2)

Publication Number Publication Date
CN109276537A true CN109276537A (en) 2019-01-29
CN109276537B CN109276537B (en) 2020-11-10

Family

ID=65180452

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811064878.6A Expired - Fee Related CN109276537B (en) 2018-09-12 2018-09-12 Composite hydrogel co-loaded with vascular disrupting agent and near-infrared photothermal response nanoparticles, and preparation and application thereof

Country Status (1)

Country Link
CN (1) CN109276537B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109912738A (en) * 2019-02-26 2019-06-21 陕西科技大学 A kind of self-repair type nano-composite emulsion and preparation method thereof
CN112773897A (en) * 2021-02-05 2021-05-11 中南大学 NIR-II photoresponse hydrogel and preparation method thereof and application of NIR-II photoresponse hydrogel in preparation of anti-cancer drugs
CN113425671A (en) * 2021-07-05 2021-09-24 郑州大学 Preparation method and application of immune gel for regulating and controlling tumor microenvironment
CN114377128A (en) * 2022-01-12 2022-04-22 中南大学 Preparation and anti-tumor application of composite hydrogel co-loaded with near-infrared photothermal agent and immune drug

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105903015A (en) * 2016-05-24 2016-08-31 上海理工大学 Multifunctional thermosensitive agarose hydrogel and preparation method and application thereof
CN106377770A (en) * 2016-09-27 2017-02-08 中南大学 Nanocomposite of black phosphorus nanosheet/copper sulfide nanoparticles as well as preparation method and application thereof
CN107456439A (en) * 2017-05-31 2017-12-12 中南大学 A kind of injectable hybridized hydrogel and preparation method and application near infrared light response property

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105903015A (en) * 2016-05-24 2016-08-31 上海理工大学 Multifunctional thermosensitive agarose hydrogel and preparation method and application thereof
CN106377770A (en) * 2016-09-27 2017-02-08 中南大学 Nanocomposite of black phosphorus nanosheet/copper sulfide nanoparticles as well as preparation method and application thereof
CN107456439A (en) * 2017-05-31 2017-12-12 中南大学 A kind of injectable hybridized hydrogel and preparation method and application near infrared light response property

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
FANG DING ET AL: "A tumor-targeting drug delivery system based on cyclic NGR-modified, combretastatin A4-loaded, functionalized graphene oxide nanosheets", 《RSC ADV.》 *
JULIANA CANO-MEJIA ET AL: "Prussian blue nanoparticle-based photothermal therapy combined with checkpoint inhibition for photothermal immunotherapy of neuroblastoma", 《NANOMEDICINE: NANOTECHNOLOGY, BIOLOGY, AND MEDICINE》 *
YUQING LIANG ET AL: "Integrated Hydrogel Platform for Programmed Antitumor Therapy Based on Near Infrared-Triggered Hyperthermia and Vascular Disruption", 《ACS APPL. MATER. INTERFACES》 *
付鲜花,等: "小分子肿瘤血管阻断剂研究进展", 《实用肿瘤杂志》 *
刘珈,等: "光热纳米材料在肿瘤治疗中的研究进展及生物反应性降解机制", 《生命科学仪器》 *
张书鹏,等: "不同形貌普鲁士蓝纳米粒子的合成及光热性能", 《高等学校化学学报》 *
张亚兰,等: "CA4 固体脂质纳米粒的制备及体外释药特性的考察", 《华西药学杂志》 *
蔡于琛,等: "小分子血管阻断剂抗肿瘤研究进展", 《药学学报》 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109912738A (en) * 2019-02-26 2019-06-21 陕西科技大学 A kind of self-repair type nano-composite emulsion and preparation method thereof
CN109912738B (en) * 2019-02-26 2020-10-13 陕西科技大学 Self-repairing nano composite emulsion and preparation method thereof
CN112773897A (en) * 2021-02-05 2021-05-11 中南大学 NIR-II photoresponse hydrogel and preparation method thereof and application of NIR-II photoresponse hydrogel in preparation of anti-cancer drugs
CN113425671A (en) * 2021-07-05 2021-09-24 郑州大学 Preparation method and application of immune gel for regulating and controlling tumor microenvironment
CN114377128A (en) * 2022-01-12 2022-04-22 中南大学 Preparation and anti-tumor application of composite hydrogel co-loaded with near-infrared photothermal agent and immune drug
CN114377128B (en) * 2022-01-12 2023-01-06 中南大学 Preparation and anti-tumor application of composite hydrogel co-loaded with near-infrared photothermal agent and immune drug

Also Published As

Publication number Publication date
CN109276537B (en) 2020-11-10

Similar Documents

Publication Publication Date Title
CN109276537A (en) A kind of composite hydrogel and its preparation and application of load vascular disrupting agents and near infrared light thermal response nanoparticle altogether
Chang et al. A multifunctional cascade bioreactor based on hollow‐structured Cu2MoS4 for synergetic cancer chemo‐dynamic therapy/starvation therapy/phototherapy/immunotherapy with remarkably enhanced efficacy
Kong et al. Arsenene-mediated multiple independently targeted reactive oxygen species burst for cancer therapy
Madsen et al. Nanoparticle-loaded macrophage-mediated photothermal therapy: potential for glioma treatment
Liang et al. Novel method using a temperature-sensitive polymer (methylcellulose) to thermally gel aqueous alginate as a pH-sensitive hydrogel
Sun et al. Nanomaterials and their composite scaffolds for photothermal therapy and tissue engineering applications
Liu et al. Functional chlorin gold nanorods enable to treat breast cancer by photothermal/photodynamic therapy
Hou et al. Injectable and natural humic acid/agarose hybrid hydrogel for localized light-driven photothermal ablation and chemotherapy of cancer
Rapp et al. Ruthenium‐Crosslinked Hydrogels with Rapid, Visible‐Light Degradation
Ciofani et al. A bi-modal approach against cancer: magnetic alginate nanoparticles for combined chemotherapy and hyperthermia
Liang et al. Integrated hydrogel platform for programmed antitumor therapy based on near infrared-triggered hyperthermia and vascular disruption
Tian et al. Polydopamine-based composite nanoparticles with redox-labile polymer shells for controlled drug release and enhanced chemo-photothermal therapy
Revuri et al. Heat‐Confined Tumor‐Docking Reversible Thermogel Potentiates Systemic Antitumor Immune Response During Near‐Infrared Photothermal Ablation in Triple‐Negative Breast Cancer
Melo et al. Chitosan-based injectable in situ forming hydrogels containing dopamine-reduced graphene oxide and resveratrol for breast cancer chemo-photothermal therapy
Yoon et al. Multifunctional nanomaterial-alginate drug delivery and imaging system for cancer therapy
Zhang et al. Enhanced postoperative cancer therapy by iron-based hydrogels
Attia et al. An updated review of mesoporous carbon as a novel drug delivery system
US9700630B2 (en) Low molecular weight methyl cellulose-based parenteral drug delivery system
Tian et al. Engineering of an endogenous hydrogen sulfide responsive smart agent for photoacoustic imaging-guided combination of photothermal therapy and chemotherapy for colon cancer
Wang et al. Reducing thermal damage to adjacent normal tissue with dual thermo-responsive polymer via thermo-induced phase transition for precise photothermal theranosis
Chai et al. A remotely controlled nanosystem for spatiotemporally specific gene regulation and combinational tumor therapy
Gan et al. Recent advances in hydrogel-based phototherapy for tumor treatment
Liu et al. An all-in-one nanoplatform with near-infrared light promoted on-demand oxygen release and deep intratumoral penetration for synergistic photothermal/photodynamic therapy
CN104069087B (en) A kind of microcapsule for the treatment of microwave tumor enhanced sensitivity and its preparation method and application
Shinde et al. Nanostructured lipid carrier-based smart gel: a delivery platform for intra-articular therapeutics

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20201110

Termination date: 20210912

CF01 Termination of patent right due to non-payment of annual fee